Mesoblast's CEO takes 30% pay cut to fund 3rd shot at cell therapy approval

cafead

Administrator
Staff member
  • cafead   Aug 31, 2023 at 10:22: AM
via Mesoblast’s CEO will “lead by example” and take a 30% pay cut as the biotech continues to reel from another FDA rejection of its off-the-shelf cell therapy.

article source